China's pharmaceutical industry 2008-2010 research

 China's pharmaceutical industry 2008-2010 research and investment advisory report
Content
2008, China's pharmaceutical economy showing the overall operation of sustained growth in industrial production, commercial purchase and sale stable momentum of growth and efficiency improvement in the level of the sound development pattern .2008 January to June, the national pharmaceutical industry completed a total investment of 43.1 billion yuan in fixed assets, an increase of 25.1%, the growth rate was significantly improved, reaching 18.1 percentage points, indicating that the pharmaceutical industry to the outside world continues to increase the attractiveness of the capital. In 2008 industrial output value of China's pharmaceutical industry, the trend growth rate of .2008 showed steadily from January to June, the pharmaceutical industry realized a total industrial output value of 375.1 billion yuan, an increase of 28.6%, the growth rate increased 5.7 percentage points. expected in 2008 the pharmaceutical industrial output value will reach about 740 billion to 760 billion yuan, an increase of about 20%.
2008, the government expenditure on medical and health sector continued to expand, the gradual improvement of universal health care system, pharmaceutical sales markets continued to the positive effect of multi-level. State for the new rural cooperative, urban medical insurance, the implementation of urban health care workers need a lot of input, which greatly promoted the growth of pharmaceutical sales market, the drugs showed rapid growth trend in consumer demand, .2008, the pharmaceutical industry industrial sales output value of steady growth, 2008 January-June total industrial sales output value of 354.5 billion yuan, an increase of 29.9%, growth rate increased 6.8 percentage points, a significant increase.
expected in 2008-2010, steady growth economic development will remain the main theme of medicine. goal: establish a strong international competitiveness of the pharmaceutical industry, part of the area into the ranks of the world's leader for power shift to the medical and lay a solid foundation. As reform and opening wider to the further deepening of the pharmaceutical industry through the vigorous promotion of industrial, product, and organizational restructuring, has entered the ever-increasing industrial concentration increasing, and further enhance the development of intrinsic motivation.
the long run, the next few years the Chinese pharmaceutical market will continue to maintain double-digit growth in 2011 is expected to rank sixth in the world. In addition, the health reform environment, accelerate the implementation of universal health care, community and rural health care system is gradually improving, drug circulation system reform is expected to expand, the demand for the release of the pharmaceutical industry and the industrial concentration will have a lot of investment opportunities. So, the development of the pharmaceutical industry in the current situation, China's pharmaceutical enterprises in the development of the industry how to analyze the current situation and future market development, industry trends, development strategies based on what?
of this report is based mainly national Bureau of Statistics, the National Development and Reform Commission, Ministry of Commerce, State Food and Drug Administration, the China Light Industry Bureau, the National Business Information Center, China Association of Pharmaceutical Commerce, Southern Medical Economic Institute, the basis of domestic and foreign publications, and pharmaceutical industry information research units and provide a large number of published data, combined with in-depth market survey data, the development of China's operation of the pharmaceutical industry, the major market segments, import and export, marketing, competition, etc. are analyzed and forecast of the future medical the overall development of the industry trend of environment and development, and judged, and finally in front of a large number of analysis, prediction, based on the research of the pharmaceutical industry's future development and investment strategies for pharmaceutical production, trade, retail and other enterprises in the fierce competition in the market insight into the opportunities, according to market needs to adjust business strategy, as strategic investors to choose the right investment opportunities and corporate leaders to do strategic planning to provide accurate information on market intelligence and scientific basis for decision making, while bank credit sector has great reference value.
appendix to National Bureau of Statistics last two years some of the latest raw data. the company based on customer requirements change in the data, such as the provinces want to have more of an understanding, companies can provide this detailed data on the provinces,UGG boots clearance, including the product yield, the main economic indicators, the import and export data, and the other for the provinces to do detailed research to fully meet customer needs.